StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Each factor shows LEGT's percentile within the scored universe — observational ranking, not a recommendation.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-15 | $11.49 | $11.08 | -3.57% | 0.1M |
| 05-18 | $11.09 | $11.11 | +0.18% | 0.0M |
| 05-19 | $11.09 | $11.09 | +0.00% | 2.0M |
| 05-20 | $11.09 | $11.08 | -0.09% | 0.2M |
| 05-21 | $11.08 | $11.09 | +0.09% | 0.0M |
Next report date, year-over-year trend, and recent quarter history.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Legato Merger Corp III is a blank check company.
No sell-side coverage available for LEGT yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
LEGT is in the extended universe. We surface dollar-volume + price-change percentiles for every US-listed name, but the full 6-factor DNA breakdown (momentum, news, sentiment, flow, relative strength) is only computed on the curated 1137-name primary list.
DNA analysis is not available for this ticker.